Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
ngenla
pfizer europe ma eeig - somatrogon - growth and development - sterum og undirstÚku hormÓn og hliÐstÆÐum - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipine vitabalans tafla 10 mg
vitabalans oy - amlodipinum besýlat - tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipin medical valley tafla 10 mg
medical valley invest ab - amlodipinum besýlat - tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipin medical valley tafla 5 mg
medical valley invest ab - amlodipinum besýlat - tafla - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipine vitabalans tafla 5 mg
vitabalans oy - amlodipinum besýlat - tafla - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipin zentiva tafla 10 mg
zentiva k.s.* - amlodipinum besýlat - tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipin zentiva tafla 2,5 mg
zentiva k.s. - amlodipinum besýlat - tafla - 2,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipin zentiva tafla 5 mg
zentiva k.s.* - amlodipinum besýlat - tafla - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipin bluefish tafla 10 mg
bluefish pharmaceuticals ab - amlodipinum besýlat - tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
amlodipin bluefish tafla 5 mg
bluefish pharmaceuticals ab - amlodipinum besýlat - tafla - 5 mg